Stabilin-1 inhibitors represent a chemical class of compounds specifically designed to selectively and reversibly target Stabilin-1, a membrane receptor with significant roles in ligand clearance, including modified lipoproteins and extracellular matrix components. These inhibitors are engineered to interact with Stabilin-1, potentially modulating its ability to bind and internalize its ligands. The chemical structure of Stabilin-1 inhibitors allows them to bind to specific regions or binding sites on the receptor, interfering with its ligand-binding functions.
Researchers employ Stabilin-1 inhibitors in biochemical and cellular studies to investigate Stabilin-1's roles in ligand clearance and cellular processes. The design and optimization of these inhibitors rely on a comprehensive understanding of Stabilin-1's structural features and its involvement in the recognition and internalization of various ligands, offering valuable tools for advancing research in the field of ligand clearance and cellular uptake pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fucoidan | 9072-19-9 | sc-255187 sc-255187A | 5 g 10 g | $190.00 $318.00 | 7 | |
Fucoidan, a sulfated polysaccharide found in various brown seaweeds, has been reported to inhibit Stabilin-1 binding to acetylated low-density lipoprotein. | ||||||
Heparin | 9005-49-6 | sc-507344 | 25 mg | $119.00 | 1 | |
Heparin has been shown to competitively inhibit Stabilin-1-mediated ligand binding. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Poly(I:C), a synthetic polypeptide, has been reported to competitively inhibit Stabilin-1 binding to its ligands. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $27.00 $2809.00 $129.00 $210.00 $583.00 $88.00 | 11 | |
A cholesterol derivative that has been studied for its potential to inhibit Stabilin-1-mediated endocytosis. | ||||||